Showing results (1331-1340 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|October 27, 2012
Extensive expansion of primary human gamma delta T cells generates cytotoxic effector memory cells that can be labeled with Feraheme for cellular MRIGabrielle M Siegers, Emeline J Ribot, Armand Keating, et al.Cancer Immunology, Immunotherapy : CII|October 31, 2012
The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancerBrian M Olson, Laura E Johnson, Douglas G McNeelCancer Immunology, Immunotherapy : CII|January 1, 1989
Augmentation of the generation of lymphokine-activated killer cells after a single dose of mitomycin C in cancer patientsS Nanbara, S Arinaga, T AkiyoshiCancer Immunology, Immunotherapy : CII|January 1, 1989
Tumor cytotoxicity of human monocyte membrane-bound interleukin-1 alpha induced by synergistic actions of interferon-gamma and synthetic acyltripeptide, FK-565N Inamura, S Sone, A Okubo, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Preadministration of a T-suppressor factor enhances tumor immunity in DBA/2 miceH Deal, J K Steele, A T Stammers, et al.Cancer Immunology, Immunotherapy : CII|February 14, 2015
The safety of allogeneic innate lymphocyte therapy for glioma patients with prior cranial irradiationLarisa Pereboeva, Lualhati Harkins, Shun Wong, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1987
Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapyL Tentori, M P Fuggetta, S D'Atri, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1985
Cytotoxic factor production by Kupffer cells elicited with Lactobacillus casei and Corynebacterium parvumS Hashimoto, Y Seyama, T Yokokura, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1985
Induction of activated macrophages by intraperitoneal injection of mitomycin C in miceH Shindo, T Ogura, T Masuno, et al.Cancer Immunology, Immunotherapy : CII|March 21, 2015
Novel strategies for inhibiting PD-1 pathway-mediated immune suppression while simultaneously delivering activating signals to tumor-reactive T cellsSuzanne Ostrand-Rosenberg, Lucas A Horn, Juan A AlvarezPageof 651